Literature DB >> 9699024

Enhanced oxidative damage in cystic fibrosis patients.

C Domínguez1, S Gartner, S Liñán, N Cobos, A Moreno.   

Abstract

Antioxidant depletion and increased free radical production by inflammatory cells have been described in cystic fibrosis (CF) patients. To evaluate oxidative damage intensity, we measured plasma concentrations of malondialdehyde, hydroperoxides and protein carbon groups as markers of oxidative injury to lipids and proteins in a group of 101 CF patients free of acute exacerbation, and in 43-112 controls. Moreover, we estimated antioxidant function by measuring activities of erythrocyte superoxide dismutase, glutathione reductase and vitamin E concentrations. In CF patients, malondialdehyde and hydroperoxide plasma levels were significantly higher than in controls (p < 0.001). Increased lipid peroxidation was documented by these two markers. Parallel rises in protein carbonyls in plasma of CF patients were observed (p < 0.0001). These patients presented biochemical but not clinical vitamin E deficiency. Glutathione reductase and superoxide dismutase activities were significantly higher than in controls. These results show a serious imbalance of CF patients between oxidant-antioxidant status leading to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699024     DOI: 10.1002/biof.5520080125

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  11 in total

1.  Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.

Authors:  J D Antuni; S A Kharitonov; D Hughes; M E Hodson; P J Barnes
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 2.  Redox balance in cystic fibrosis.

Authors:  Assem G Ziady; Jason Hansen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-20       Impact factor: 5.085

3.  Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Authors:  Vihas T Vasu; Sharon J de Cruz; Jessica S Houghton; Keri A Hayakawa; Brian M Morrissey; Carroll E Cross; Jason P Eiserich
Journal:  Free Radic Res       Date:  2010-10-18

4.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

Review 5.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

6.  A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Authors:  Chirag Kariya; Heather Leitner; Elysia Min; Christiaan van Heeckeren; Anna van Heeckeren; Brian J Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-16       Impact factor: 5.464

7.  Sildenafil improves vascular endothelial function in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Nichole Lee; Matthew A Tucker; Gábor Csányi; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-31       Impact factor: 4.733

8.  Flaxseed modulates inflammatory and oxidative stress biomarkers in cystic fibrosis: a pilot study.

Authors:  Jason B Turowski; Ralph A Pietrofesa; John A Lawson; Melpo Christofidou-Solomidou; Denis Hadjiliadis
Journal:  BMC Complement Altern Med       Date:  2015-05-13       Impact factor: 3.659

9.  The inhibition of superoxide production by the soluble phase of cystic fibrosis sputum.

Authors:  Amrita Dosanjh
Journal:  Open Respir Med J       Date:  2008-11-07

Review 10.  Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.

Authors:  Adam J Causer; Janis K Shute; Michael H Cummings; Anthony I Shepherd; Mathieu Gruet; Joseph T Costello; Stephen Bailey; Martin Lindley; Clare Pearson; Gary Connett; Mark I Allenby; Mary P Carroll; Thomas Daniels; Zoe L Saynor
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.